Jason Amello - Net Worth and Insider Trading
Jason Amello Net Worth
The estimated net worth of Jason Amello is at least $246,385 dollars as of 2024-05-10. Jason Amello is the SVP, CFO & Treasurer of Akebia Therapeutics Inc and owns about 144,642 shares of Akebia Therapeutics Inc (AKBA) stock worth over $190,927. Jason Amello is also the CFO of Candel Therapeutics Inc and owns about 5,568 shares of Candel Therapeutics Inc (CADL) stock worth over $55,457. Details can be seen in Jason Amello's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jason Amello has not made any transactions after 2022-12-09 and currently still holds the listed stock(s).
Transaction Summary of Jason Amello
Jason Amello Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jason Amello owns 4 companies in total, including Akebia Therapeutics Inc (AKBA) , Acer Therapeutics Inc (ACER) , and Alaunos Therapeutics Inc (TCRT) among others .
Click here to see the complete history of Jason Amello’s form 4 insider trades.
Insider Ownership Summary of Jason Amello
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2020-02-28 | SVP & CFO & Treasurer |
| ACER | Acer Therapeutics Inc | 2019-02-01 | director |
| TCRT | Alaunos Therapeutics Inc | 2012-05-08 | Executive Vice President & CFO |
 | | 2022-12-09 | Chief Financial Officer |
Jason Amello Latest Holdings Summary
Jason Amello currently owns a total of 2 stocks. Among these stocks, Jason Amello owns 144,642 shares of Akebia Therapeutics Inc (AKBA) as of February 28, 2020, with a value of $190,927 and a weighting of 77.49%. Jason Amello also owns 5,568 shares of Candel Therapeutics Inc (CADL) as of December 9, 2022, with a value of $55,457 and a weighting of 22.51%.
Latest Holdings of Jason Amello
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2020-02-28 | 144,642 | 1.32 | 190,927 |
| CADL | Candel Therapeutics Inc | 2022-12-09 | 5,568 | 9.96 | 55,457 |
Holding Weightings of Jason Amello
Jason Amello Form 4 Trading Tracker
According to the SEC Form 4 filings, Jason Amello has made a total of 1 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 6,976 shares on February 28, 2020, which brought Jason Amello around $60,691.
According to the SEC Form 4 filings, Jason Amello has made a total of 1 transactions in Candel Therapeutics Inc (CADL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Candel Therapeutics Inc is the acquisition of 5,568 shares on December 9, 2022, which cost Jason Amello around $10,022.
Insider Trading History of Jason Amello
- 1
Jason Amello Trading Performance
GuruFocus tracks the stock performance after each of Jason Amello's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason Amello is -16.27%. GuruFocus also compares Jason Amello's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason Amello within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jason Amello's insider trading performs compared to the benchmark.
Performance of Jason Amello
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.26 | | | | | |
| Relative Return to S&P 500(%) | -4.19 | | | | | |
Jason Amello Ownership Network
Jason Amello Owned Company Details
What does Akebia Therapeutics Inc do?
Who are the key executives at Akebia Therapeutics Inc?
Jason Amello is the SVP & CFO & Treasurer of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Business Officer Michel Dahan , director & CEO & President John P. Butler , and SVP & General Counsel & Sec. Nicole R. Hadas .
Akebia Therapeutics Inc (AKBA) Insider Trades Summary
Over the past 18 months, Jason Amello made no insider transaction in Akebia Therapeutics Inc (AKBA). Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 127,765 shares made by Steven Keith Burke , a net sale of 145,385 shares made by Michel Dahan , and a net sale of 96,282 shares made by Nicole R. Hadas .
In summary, during the past 3 months, insiders sold 132,629 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 132,629 shares. During the past 18 months, 662,551 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 662,551 shares.
Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akebia Therapeutics Inc Insider Transactions
Jason Amello Mailing Address
Above is the net worth, insider trading, and ownership report for Jason Amello. You might contact Jason Amello via mailing address: 500 Kendall Street, Cambridge Ma 01824.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
